Hypercoagulability After Breast Cancer Surgery

Plasma Coagulation Parameters and Hypercoagulability After Breast Cancer Surgery

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00210197

Acronym

EHC

Enrollment

Registered

2005-09-21

Start date

2005-01-31

Completion date

2006-01-31

Last updated

2013-07-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Coagulation Disorders, Breast Cancer

Keywords

Hypercoagulability, Plasma coagulation parameters, Breast cancer

Brief summary

The risk of deep venous thrombosis after radical breast surgery is known. The objective of this study is to explore hypercoagulability after radical breast cancer surgery by studying several factors for haemostasis before, during and after surgery. Ultrasound Doppler examination is realised between 24 and 72 hours post-operatively. Hypercoagulability is defined by a significant increasing level of thrombin-antithrombin, D-dimer and the endogen thrombin potential.

Interventions

PROCEDUREBlood collection (pre and postoperative): plasma coagulation parameters

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Breast cancer * mastectomy

Exclusion criteria

* thrombophilia * anticoagulant treatment

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026